S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GTHX G1 Therapeutics Inc

4.49

0.05 (1.13%)

May 03 2024 - Closed

Delayed by 15 minutes

G1 Therapeutics EPS beats by $0.42, beats on revenue

To read the full story on Seeking Alpha, click here.

G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more G1 Therapeutics Charts.

G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more G1 Therapeutics Charts.

G1 Therapeutics Inc News

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 1 May 2024 (3 days ago) • GlobeNewswire Inc.

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
Wednesday 1 May 2024 (4 days ago) • GlobeNewswire Inc.

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
Wednesday 1 May 2024 (4 days ago) • GlobeNewswire Inc.

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
Wednesday 17 April 2024 (3 weeks ago) • GlobeNewswire Inc.

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
Thursday 15 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

More G1 Therapeutics Inc News Articles

Code Green Apparel (PK)

1812 Brewing (PK)

Anavex Life Sciences

Rennova Health (PK)

Digital Brand Media and ... (PK)

Kraig Biocraft Laborator... (QB)

Voip Pal Com (QB)

Good Vibrations Shoes (PK)

Trump Media and Technology

AMC Entertainment

Impact Fusion (PK)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions